Literature DB >> 21323576

Nucleic acid binding behaviors and cytotoxic properties of a Ru(II) complex.

Li-Feng Tan1, Fu-Cang Song, Xiao-Qin Zou, Xi-Ling Ling.   

Abstract

The interactions of complex [Ru(bpy)(2)(hnip)](2+) (1) {bpy = 2,2'-bipyridine, hnip = 2-(2-hydroxy-1-naphthyl)imidazo[4,5-f][1,10]phenanthroline} with calf thymus DNA and yeast tRNA were investigated by UV-vis spectroscopy, fluorescence spectroscopy, viscosity, equilibrium dialysis, and circular dichroism. In addition, the antitumor activities of complex 1 were evaluated with MTT method. These results indicate that the structures of DNA and RNA have significant effects on the binding behaviors of complex 1. Further, complex 1 demonstrates different antitumor activities against selected cancer cell lines in vitro.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21323576     DOI: 10.1089/dna.2010.1137

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  3 in total

1.  Binding properties of Ru(II) polypyridyl complexes with poly(U)·poly(A)*poly(U) triplex: the ancillary ligand effect on third-strand stabilization.

Authors:  Li-Feng Tan; Ling-Jun Xie; Xiao-Nan Sun
Journal:  J Biol Inorg Chem       Date:  2012-10-31       Impact factor: 3.358

2.  Synthesis, characterization, and DNA binding, photocleavage, cytotoxicity, cellular uptake, apoptosis, and on-off light switching studies of Ru(II) mixed-ligand complexes containing 7-fluorodipyrido[3,2-a:2',3'-c]phenazine.

Authors:  Nancherla Deepika; Yata Praveen Kumar; Chittimalli Shobha Devi; Putta Venkat Reddy; Avudoddi Srishailam; Sirasani Satyanarayana
Journal:  J Biol Inorg Chem       Date:  2013-07-12       Impact factor: 3.358

3.  Molecular aspects on the interaction of isatin-3-isonicotinylhydrazone to deoxyribonucleic acid: model for intercalative drug-DNA binding.

Authors:  Soheila Kashanian; Mohammad Mehdi Khodaei; Parvaneh Pakravan; Hadi Adibi
Journal:  Mol Biol Rep       Date:  2011-07-21       Impact factor: 2.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.